Heart Failure 2019 - 6th World Congress on Acute Heart Failure

25 - 28 May 2019, Athens - Greece

Session Details

Late breaking trial III - Innovative and device therapy
Mon 27 May 08:30 - 10:00 Device Therapy Special Session, Mobile App - Ask a Question Trianti - lecture room
Chairpersons: Stefan ANKER (Berlin, Germany), Andrew COATS (Coventry, United Kingdom of Great Britain & Northern Ireland)

Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
08:30 Reduction of Mitral Regurgitation in Patients with Heart Failure and Secondary Mitral Regurgitation: Relationship Between Baseline Biomarkers and Outcomes from the COAPT TrialWilliam ABRAHAM (Columbus, United States of America)
08:401293Discussion - COAPT.Nathan MEWTON (Bron, FR)
08:45 A first in human multi-center, open label, prospective study to evaluate the safety, usability and performance of the V-LAP systemWilliam ABRAHAM (Columbus, United States of America)
08:551294Discussion - A first in human multi-center, open label, prospective study to evaluate the safety, usability and performance of the V-LAP system.Finn GUSTAFSSON (Copenhagen, DK)
09:00 Cardiac contractility modulation (CCM) in HFrEF NYHA Class III patientsDaniel BURKHOFF (New York, United States of America)
09:101295Discussion - Cardiac contractility modulation (CCM) in HFrEF NYHA Class III patients.Andrew COATS (Coventry, GB)
09:15 Alteration in acquired von willebrand factor with centrifugal or axial flow left ventricular assist devices: a prospective, multicenter clinical trialA BANSAL (New Orleans, United States of America)
09:251296Discussion - Alteration in acquired von willebrand factor with centrifugal or axial flow left ventricular assist devices: a prospective, multicenter clinical trial. 
09:30 First in human experience with direct sodium removal using a zero sodium peritoneal solution: a new candidate therapy for volume overloadJeffrey TESTANI (New Haven, United States of America)
09:401297Discussion - First in human experience with direct sodium removal using a zero sodium peritoneal solution: a new candidate therapy for volume overload.Patrick ROSSIGNOL (Vandoeuvre Les Nancy, FR)
09:45 Baroreflex Activation Therapy in Patients with Heart Failure with a Reduced Ejection Fraction.Joann LINDENFELD (Nashville, United States of America)
09:55 Discussion - Baroreflex Activation Therapy in Patients with Heart Failure with a Reduced Ejection Fraction.Andrew COATS (Coventry, GB)